Antimalarial Activity of Newly Synthesized Chalcone Derivatives In Vitro

Chemical Biology and Drug Design

Volumn 80, Issue 2, 2012, Pages 340-347

  Yadav, Neesha ^a   Dixit, Sandeep K ^a   Bhattacharya, Amit ^a   Mishra, Lokesh C ^a   Sharma, Manish ^a   Awasthi, Satish K ^a   Bhasin, Virendra K ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Antimalarial activity; Chalcone synthesis; in vitro; Plasmodium falciparum

Indexed keywords

1 (4 BENZIMIDAZOL 1 YLPHENYL) 3 (2,4 DIMETHOXYPHENYL)PROPEN 1 ONE; ANTIMALARIAL AGENT; CHALCONE DERIVATIVE; CYSTEINE PROTEINASE; FUNCTIONAL GROUP; LICOCHALCONE A; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; CLAISEN CONDENSATION; CLAISEN SCHMIDT CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVE SITE; IC 50; IN VITRO STUDY; NONHUMAN; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEINASE INHIBITION; REVIEW; STEREOSPECIFICITY;

ANTIMALARIALS; CHALCONE; ERYTHROCYTES; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 84864013231     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2012.01383.x     Document Type: Review

References (23)

1. Phillips R.S. (2001) Current status of malaria and potential for control. Clin Microbiol Rev;14:208-226.
2. Nielsen S.F., Bosen T., Larsen M., Schonning K., Kromann H. (2004) Antibacterial chalcones - bioisosteric replacement of the 4′-hydroxy group. Bioorg Med Chem;12:3047-3054.
3. Nielsen S.F., Larsen M., Bosen T., Schonning K., Kromann H. (2005) Cationic chalcone antibiotics: design, synthesis, and mechanism of action. J Med Chem;48:2667-2677.
4. Awasthi S.K., Mishra N., Dixit S.K., Singh A., Yadav M., Yadav S.S., Rathaur S. (2009) Antifilarial activity of 1, 3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme. Am J Trop Med Hyg;80:764-768.
5. Wood J.E., Munro M.H.G., Blunt J.W., Perry N.B., Walker J.R.C., Ward J.M. (1999) Biologically active compounds from Ozothamnus leptophyllus. N Z J Bot;37:167-174.
6. Cheenpracha S., Karalai C., Ponglimanont C., Subhadhirasakul S., Tewtrakal S. (2006) Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorg Med Chem;14:1710-1714.
7. Liu M., Wilairat P., Croft S.L., Tan A.L., Go M.L. (2003) Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg Med Chem;11:2729-2738.
8. Robinson P.T., Hubbard R.B. IV, Ehlers T.J., Arbiser J.L., Goldsmith D.J., Bowen J.P. (2005) Synthesis and biological evaluation of aromatic enones related to curcumin. Bioorg Med Chem;13:4007-4013.
9. Rao Y.K., Fang F.S., Tzeng Y.M. (2004) Differential effects of synthesized 2′-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution. Bioorg Med Chem;122:2679-2686.
10. Chen M., Theander T.G., Christensen B.S., Hviid I., Zhai L., Kharazmi A. (1994) Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother;38:1470-1475.
11. Mishra N., Arora P., Kumar B., Mishra L.C., Bhattacharya A., Awasthi S.K., Bhasin V.K. (2008) Synthesis of novel substituted 1, 3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur J Med Chem;43:1530-1535.
12. Mishra L.C., Bhattacharya A., Bhasin V.K. (2009) Phytochemical licochalcone A enhances antimalarial activity of artemisinin in vitro. Acta Trop;109:194-198.
13. Awasthi S.K., Mishra N., Kumar B., Sharma M., Bhattacharya A., Mishra L.C., Bhasin V.K. (2009) Potent antimalarial activity of newly synthesized substituted chalcone analogs in vitro. Med Chem Res;18:407-420.
14. Li R., Kenyon G.L., Cohen F.E., Chen X., Gong B., Dominguez D.E., Kurzban G., Miller R.E., Nuzum E.O., Rosenthal P.J., McKerrow J.H. (1995) In vitro antimalarial activity of chalcones and their derivatives. J Med Chem;38:5031-5037.
15. Khatib S., Nerya O., Musa R., Shmuel M., Tamir S., Vaya J. (2005) Chalcones as potent tyrosinase inhibitors: the importance of a 2, 4-substituted resorcinol moiety. Bioorg Med Chem;13:433-441.
16. Trager W., Jensen J.B. (1976) Human malaria parasites in continuous culture. Science;193:673-675.
17. Bhattacharya A., Mishra L.C., Sharma M., Awasthi S.K., Bhasin V.K. (2009) Antimalarial pharmacodynamics of chalcone derivatives in combination with artemisinin against Plasmodium falciparum in vitro. Eur J Med Chem;44:3388-3393.
18. Lambros C., Vanderberg J.P. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol;65:418-420.
19. Nguyen-Dinh P., Payne D. (1980) Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull World Health Organ;58:909-912.
20. Olliaro P.L., Goldberg D.E. (1995) The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol Today;11:294-297.
21. Gamboa de Dominguez N.D., Rosenthal P.J. (1996) Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood;87:4448-4454.
22. Francis S.E., Sullivan D.J., Goldberg D.E. (1997) Hemoglobin metabolism in the malaria parasite, Plasmodium falciparum. Annu Rev Microbiol;51:97-123.
23. Li R., Chen X., Gong B., Selzer P.M., Li Z., Davidson E., Kurzban G. et al. (1996) Structure-based design of parasitic protease inhibitors. Bioorg Med Chem;4:1421-1422.